Synergy CHC (SNYR) Stock Price, News & Analysis

Company Overview

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.

Key Stats

• Today's Range: $0.19 to $0.23
• 50-Day Range: $0.21 to $1.29
• 52-Week Range: $0.19 to $4.00
• Volume: 987,142 shs
• Average Volume: 6.79 million shs
• Market Capitalization: $3.15 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.25
• Consensus Rating: Hold

Synergy CHC Stock Analysis - MarketRank™

Synergy CHC scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.6 / 5
• Analyst Rating: Hold

Consensus Rating

Synergy CHC has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Synergy CHC has a consensus price target of $6.25, representing about 2,896.2% upside from its current price of $0.21.

Amount of Analyst Coverage

Synergy CHC has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 84.62%

Earnings Growth

Earnings for Synergy CHC are expected to grow by 84.62% in the coming year, from $0.13 to $0.24 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Synergy CHC is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Synergy CHC is -0.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.56% of the float of Synergy CHC has been sold short.

Short Interest Ratio / Days to Cover

Synergy CHC has a short interest ratio ("days to cover") of 0.21, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Synergy CHC has recently increased by 1.81%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Synergy CHC does not currently pay a dividend.

Dividend Growth

Synergy CHC does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Synergy CHC this week, compared to 2 articles on an average week.

Search Interest

Only 2 people have searched for SNYR on MarketBeat in the last 30 days. This is a decrease of -82% compared to the previous 30 days.

MarketBeat Follows

2 people have added Synergy CHC to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Synergy CHC insiders have not sold or bought any company stock.

Percentage Held by Insiders

56.60% of the stock of Synergy CHC is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Synergy CHC has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 5/14/2026
• Today: 6/08/2026
• AGM 2026: 6/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: CONS PD - MISC STPL
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:SNYR
• CIK: 1562733
• Web: synergychc.com
• Phone: (207) 321-2350
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Synergy CHC: $6.25
• High Price Target: $7.00
• Low Price Target: $5.50
• Potential Upside/Downside: +2,896.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 1.60
• P/E Growth: N/A
• Net Income: -$12.34 million
• Net Margins: -60.02%
• Pretax Margin: -59.58%
• Return on Equity: -19.51%
• Return on Assets: -30.30%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.93
• Quick Ratio: 0.43

Sales & Book Value

• Annual Sales: $27.70 million
• Price / Sales: 0.11
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($2.06) per share
• Price / Book: -0.10

Miscellaneous

• Outstanding Shares: 15,080,000
• Free Float: 6,545,000
• Market Cap: $3.15 million
• Optionable: N/A
• Beta: -0.27